Standout Papers

The 2016 revision of the World Health Organization classification of lympho... 2013 2026 2017 2021 4.7k
  1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms (2016)
    Steven H. Swerdlow, Elı́as Campo et al. Blood
  2. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era (2013)
    Zheng Zhou, Laurie H. Sehn et al. Blood
  3. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study (2015)
    Carla Casulo, Michelle Byrtek et al. Journal of Clinical Oncology

Immediate Impact

20 by Nobel laureates 34 from Science/Nature 87 standout
Sub-graph 1 of 20

Citing Papers

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
1 intermediate paper

Works of Andrew D. Zelenetz being referenced

The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis
1993

Author Peers

Author Last Decade Papers Cites
Andrew D. Zelenetz 13315 5739 8288 369 18.6k
Christian Gisselbrecht 14822 5293 11387 283 19.6k
Hervé Tilly 16724 6603 11273 412 21.9k
Ranjana H. Advani 12994 5305 9864 450 19.3k
Corinne Haïoun 13667 4416 8254 396 17.3k
Andreas Engert 11883 4050 9034 551 20.2k
Emanuele Zucca 15590 4921 8123 398 20.3k
Anas Younes 11335 4901 10689 525 21.6k
Fernando Cabanillas 17913 7347 12749 468 25.6k
Anton Hagenbeek 11213 4149 7618 257 16.0k
Georges Delsol 14384 4650 9504 269 21.2k

All Works

Loading papers...

Rankless by CCL
2026